FDA issued a Warning Letter to Glenmark Pharmaceuticals Limited on 10/3/2019 for a later inspection.
483 Glenmark Pharmaceuticals Nov 2017

483 Glenmark Pharmaceuticals Nov 2017

Jogy George FDA, Dipesh Shah FDA$119.00 - Available Now

FDA investigators audited the Glenmark Pharmaceuticals - Solan, India facility and issued inspectional observations (via FDA 483) on 11 Nov 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 11 Nov 2017
  • Location: Solan, India
  • FEI: 3005757050
Add To Cart